Efficacy and safety analysis of induction therapy for unresectable locally advanced non-small-cell lung cancer: a retrospective study based on IPTW
Background Concurrent chemoradiotherapy (cCRT) followed by consolidation immunotherapy constitutes the current standard of care for unresectable locally advanced non–small cell lung cancer (LA-NSCLC). Despite this approach, a substantial proportion of patients experience disease progression, underscoring the need for n...